Adage Capital Partners’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
4,424,868
+449,868
| +11% | +$1.17M | 0.02% | 587 |
|
|
2025
Q1 | $7.55M | Sell |
3,975,000
-2,019,810
| -34% | -$3.84M | 0.01% | 637 |
|
|
2024
Q4 | $8.69M | Sell |
5,994,810
-5,135,190
| -46% | -$7.45M | 0.02% | 638 |
|
|
2024
Q3 | $20.5M | Hold |
11,130,000
| – | – | 0.04% | 442 |
|
|
2024
Q2 | $11.1M | Hold |
11,130,000
| – | – | 0.02% | 577 |
|
|
2024
Q1 | $22M | Buy |
11,130,000
+1,250,000
| +13% | +$2.48M | 0.04% | 423 |
|
|
2023
Q4 | $15.4M | Buy |
9,880,000
+3,500,000
| +55% | +$5.46M | 0.03% | 500 |
|
|
2023
Q3 | $12.6M | Buy |
6,380,000
+130,000
| +2% | +$256K | 0.03% | 523 |
|
|
2023
Q2 | $19.9M | Hold |
6,250,000
| – | – | 0.04% | 405 |
|
|
2023
Q1 | $20.4M | Buy |
6,250,000
+475,200
| +8% | +$1.55M | 0.05% | 408 |
|
|
2022
Q4 | $29M | Buy |
5,774,800
+1,168,200
| +25% | +$5.88M | 0.07% | 325 |
|
|
2022
Q3 | $10.5M | Buy |
4,606,600
+200,000
| +5% | +$456K | 0.03% | 624 |
|
|
2022
Q2 | $11.7M | Buy |
4,406,600
+2,129,600
| +94% | +$5.64M | 0.03% | 633 |
|
|
2022
Q1 | $3.12M | Buy |
2,277,000
+877,000
| +63% | +$1.2M | 0.01% | 873 |
|
|
2021
Q4 | $4.44M | Buy |
+1,400,000
| New | +$4.44M | 0.01% | 826 |
|